TIRZEPATIDE

Description

Research focus: Glucose and appetite signaling

Activates GIP and GLP-1 receptors involved in insulin release and appetite signaling.

Tirzepatide is a dual receptor agonist studied in metabolic regulation. Research material is not interchangeable with a licensed prescription formulation.

Evidence context: Receptor and clinical research

Read background source

Research findings describe the named compound, not verified results for a Peptix batch. For laboratory research use only. Not for human or animal consumption. Not for diagnostic or therapeutic use.